期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 11, 期 9, 页码 3209-3225出版社
MDPI AG
DOI: 10.3390/ijms11093209
关键词
biomarkers; colorectal cancer; fecal biomarkers; genomic and epigenetic biomarkers; serum biomarkers; microRNA
资金
- Ministry of Health, Labour and Welfare of Japan
- Ministry of Education, Culture, Sports, Science and Technology of Japan [18592076, 17015016, 18880030]
- High-Technology Center of Kanazawa Medical University [H2010-12]
Colorectal cancer (CRC) is the third most common epithelial malignancy in the world. Since CRC develops slowly from removable precancerous lesions, detection of the lesion at an early stage by regular health examinations can reduce the incidence and mortality of this malignancy. Colonoscopy significantly improves the detection rate of CRC, but the examination is expensive and inconvenient. Therefore, we need novel biomarkers that are non-invasive to enable us to detect CRC quite early. A number of validation studies have been conducted to evaluate genetic, epigenetic or protein markers for identification in the stool and/or serum. Currently, the fecal occult blood test is the most widely used method of screening for CRC. However, advances in genomics and proteomics will lead to the discovery of novel non-invasive biomarkers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据